Jason Haas sold $2.1M of Ligand Pharmaceuticals Incorporated (LGND)

Executed Aug 12, disclosed Aug 14, 2 days later.

Value, as filed

$2.1M

7,138 sh × $292.81

Executed

Aug 12

the trade date, as filed

Disclosed

Aug 14

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jason Haas Director profile →

Jason Haas (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Ligand Pharmaceuticals Incorporated (LGND). The largest single filing was $2.1M of LGND (7,138 sh × $292.81, as filed), executed Aug 12.

The name

LGND

Ligand Pharmaceuticals Incorporated LGND · Healthcare · 36 filings in 24 months ticker →

Healthcare · Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jason Haas in LGND

LGNDSALE Ligand Pharmaceuticals Incorporated $1.7M
6,461 sh across 2 lots
Exec Jun 12
Filed Jun 15 · 5:30 PM ET